CompletedN/AMDMA

Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]

Sponsored by California Pacific Medical Center Research Institute

NCT ID
NCT00823407
Target Enrollment
12 participants
Start Date
2009-01
Est. Completion
2009-07

About This Study

The purpose of this study is to investigate the pharmacological and cognitive effects of MDA in healthy humans.

Conditions Studied

Healthy

Interventions

  • •MDA
  • •Placebo

Eligibility

Age:18 Years - 50 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* Healthy males and females age 18-50
* Fluent English speaker
* Willing and able to give written consent

Exclusion Criteria:

* Body mass index \> 30 or \< 18
* Pregnancy or lactation

FOR MORE DETAILS CONTACT THE RESEARCH CLINIC.

Study Locations (1)

CPMC Addiction & Pharmacology Research Laboratory (APRL)
San Francisco, California, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine] | Huxley